首页 > 最新文献
paperpass

Journal of Food and Drug Analysis最新文献

英文 中文
In vitro digestion modifies Lepidium meyenii extract, altering its major glucosinolates, lepidilines, β-carbolines, and gut bacterial growth. 体外消化改变了枸杞提取物,改变了其主要的硫代葡萄糖苷、枸杞碱、β-碳碱和肠道细菌生长。
IF 3.3 3区 农林科学 Q2 FOOD SCIENCE & TECHNOLOGY Pub Date : 2026-09-01 DOI: 10.38212/2224-6614.3602
Dominik Tarabasz, Ewa Baranowska-Wójcik, Paweł Szczeblewski, Tomasz Laskowski, Klaudia Gustaw, Marzena Furtak-Niczyporuk, Dominik Szwajgier, Rita Cristina Orihuela-Campos, Henry O Meissner, Julia Borzyszkowska-Bukowska, Wirginia Kukula-Koch

The tubers of Lepidium meyenii (commonly known as maca) have been used in the Andean cuisine for ages. The study aims to determine the behavior of the extract from the red phenotype of maca in the in vitro gastrointestinal tract model and also to define the overall impact of the extract on the microbiota. Glucosinolates, lepidilines, and a derivative of β-carboline alkaloid, i.e. 1-methyltetrahydro-β-5,6-hydride-carboline-3-carboxylic acid, as representatives of one of the main groups of metabolites were selected for the quantitative analysis after in vitro digestion at every stage of the digestion model. The results showed that lepidilines remained highly stable throughout the digestive simulation, whereas glucosinolates and the β-carboline derivative were substantially degraded, under the influence of the enzymes and bacteria applied in the "large intestine". In addition, the red maca extract exhibited prebiotic activity by promoting the growth of selected lactic acid bacteria, with Lactococcus lactis showing the most pronounced response, suggesting that maca-derived preparations may hold promising potential as ingredients in functional foods and microbiota-targeted nutritional formulations.

Lepidium meyenii(俗称玛卡)的块茎已经在安第斯烹饪中使用了很长时间。本研究旨在确定玛咖红色表型提取物在体外胃肠道模型中的行为,并确定提取物对微生物群的总体影响。在消化模型的每个阶段体外消化后,选择硫代葡萄糖苷、大麻碱和β-羰基生物碱的衍生物1-甲基四氢-β-5,6-氢化-羰基-3-羧酸作为主要代谢物组的代表进行定量分析。结果表明,在整个消化模拟过程中,lepidilines保持高度稳定,而在“大肠”中应用的酶和细菌的影响下,硫代葡萄糖苷和β-碳碱衍生物被大量降解。此外,红色玛咖提取物通过促进特定乳酸菌的生长而显示出益生元活性,其中乳酸乳球菌表现出最明显的反应,这表明玛咖衍生制剂可能在功能食品和针对微生物群的营养配方中具有很大的潜力。
{"title":"In vitro digestion modifies Lepidium meyenii extract, altering its major glucosinolates, lepidilines, β-carbolines, and gut bacterial growth.","authors":"Dominik Tarabasz, Ewa Baranowska-Wójcik, Paweł Szczeblewski, Tomasz Laskowski, Klaudia Gustaw, Marzena Furtak-Niczyporuk, Dominik Szwajgier, Rita Cristina Orihuela-Campos, Henry O Meissner, Julia Borzyszkowska-Bukowska, Wirginia Kukula-Koch","doi":"10.38212/2224-6614.3602","DOIUrl":"10.38212/2224-6614.3602","url":null,"abstract":"<p><p>The tubers of Lepidium meyenii (commonly known as maca) have been used in the Andean cuisine for ages. The study aims to determine the behavior of the extract from the red phenotype of maca in the in vitro gastrointestinal tract model and also to define the overall impact of the extract on the microbiota. Glucosinolates, lepidilines, and a derivative of β-carboline alkaloid, i.e. 1-methyltetrahydro-β-5,6-hydride-carboline-3-carboxylic acid, as representatives of one of the main groups of metabolites were selected for the quantitative analysis after in vitro digestion at every stage of the digestion model. The results showed that lepidilines remained highly stable throughout the digestive simulation, whereas glucosinolates and the β-carboline derivative were substantially degraded, under the influence of the enzymes and bacteria applied in the \"large intestine\". In addition, the red maca extract exhibited prebiotic activity by promoting the growth of selected lactic acid bacteria, with Lactococcus lactis showing the most pronounced response, suggesting that maca-derived preparations may hold promising potential as ingredients in functional foods and microbiota-targeted nutritional formulations.</p>","PeriodicalId":358,"journal":{"name":"Journal of Food and Drug Analysis","volume":"34 3","pages":"373-391"},"PeriodicalIF":3.3,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13592842/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149056670","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Urinary antimony as a biomarker for differentiating heroin and Brown mixture use. 尿锑作为区分海洛因和布朗混合物的生物标志物。
IF 3.3 3区 农林科学 Q2 FOOD SCIENCE & TECHNOLOGY Pub Date : 2026-09-01 DOI: 10.38212/2224-6614.3603
Shu-Mei Tsai, Yu-Han Hsiao, Yan-Zin Chang, Sai-Wai Ho

Heroin is classified as a Schedule I controlled substance with severe legal consequences for its use, whereas liquid Brown Mixture (BM) is a legally available and commonly prescribed cough remedy in Taiwan. However, numerous cases of BM ingestion have been misinterpreted as heroin use because BM contains opium tincture, leading to similar urine test results. Owing to the rapid metabolism of heroin, detection of the parent drug and its primary metabolite, 6-acetylmorphine, in urine is difficult; thus, interpretation often relies on morphine concentration and the morphine-to-codeine (M/C) ratio, which can be inconclusive. In our BM analysis, the M/C ratio was 3.3 ± 0.4, and among 5094 morphine-positive urine samples, 279 (5.5%) had M/C ratios between 2 and 4, suggesting that a substantial number of individuals could be misidentified. Given the lack of reliable urinary biomarkers to distinguish BM from heroin use, this study aimed to identify BM-specific indicators. BM contains antimony (Sb) potassium tartrate, an emetic agent absent in heroin formulations. Although urinary Sb levels are low, they can be quantified using highly sensitive inductively coupled plasma mass spectrometry (ICP-MS). A pharmacokinetic study involving single and multiple BM doses revealed that urinary Sb increased from ≤0.11 ng/mL pre-dose to 0.4-98.9 ng/mL post-dose. Morphine and codeine were determined using gas chromatography-mass spectrometry (GC-MS), and M/C ratios ranged from 2.0 to 14.9, showing a secondary rise at later stages. These findings suggest that urinary Sb may serve as a useful supplementary biomarker for BM ingestion, thereby enhancing the accuracy of forensic toxicological interpretation and reducing false identification of heroin use.

海洛因被列为附表1管制物质,使用后会有严重的法律后果,而液体棕色混合物(BM)在台湾是一种合法的、常用的止咳药。然而,由于BM含有鸦片酊剂,许多摄取BM的病例被误解为使用海洛因,导致尿检结果相似。由于海洛因的快速代谢,在尿液中检测母体药物及其主要代谢物6-乙酰吗啡是困难的;因此,解释通常依赖于吗啡浓度和吗啡与可待因(M/C)比率,这可能是不确定的。在我们的BM分析中,M/C比率为3.3±0.4,在5094份吗啡阳性尿样中,279份(5.5%)的M/C比率在2到4之间,这表明有相当数量的个体可能被错误识别。鉴于缺乏可靠的尿液生物标志物来区分BM和海洛因使用,本研究旨在确定BM特异性指标。BM含有锑(Sb)酒石酸钾,一种在海洛因配方中不存在的催吐剂。虽然尿Sb水平较低,但可以使用高灵敏度电感耦合等离子体质谱(ICP-MS)进行定量。单次和多次给药的药代动力学研究显示,尿Sb从给药前≤0.11 ng/mL增加到给药后的0.4-98.9 ng/mL。吗啡和可待因采用气相色谱-质谱联用(GC-MS)测定,M/C比值在2.0 ~ 14.9之间,后期有二次升高。这些发现表明,尿Sb可以作为一种有用的补充生物标志物,用于BM摄入,从而提高法医毒理学解释的准确性,减少海洛因使用的错误识别。
{"title":"Urinary antimony as a biomarker for differentiating heroin and Brown mixture use.","authors":"Shu-Mei Tsai, Yu-Han Hsiao, Yan-Zin Chang, Sai-Wai Ho","doi":"10.38212/2224-6614.3603","DOIUrl":"10.38212/2224-6614.3603","url":null,"abstract":"<p><p>Heroin is classified as a Schedule I controlled substance with severe legal consequences for its use, whereas liquid Brown Mixture (BM) is a legally available and commonly prescribed cough remedy in Taiwan. However, numerous cases of BM ingestion have been misinterpreted as heroin use because BM contains opium tincture, leading to similar urine test results. Owing to the rapid metabolism of heroin, detection of the parent drug and its primary metabolite, 6-acetylmorphine, in urine is difficult; thus, interpretation often relies on morphine concentration and the morphine-to-codeine (M/C) ratio, which can be inconclusive. In our BM analysis, the M/C ratio was 3.3 ± 0.4, and among 5094 morphine-positive urine samples, 279 (5.5%) had M/C ratios between 2 and 4, suggesting that a substantial number of individuals could be misidentified. Given the lack of reliable urinary biomarkers to distinguish BM from heroin use, this study aimed to identify BM-specific indicators. BM contains antimony (Sb) potassium tartrate, an emetic agent absent in heroin formulations. Although urinary Sb levels are low, they can be quantified using highly sensitive inductively coupled plasma mass spectrometry (ICP-MS). A pharmacokinetic study involving single and multiple BM doses revealed that urinary Sb increased from ≤0.11 ng/mL pre-dose to 0.4-98.9 ng/mL post-dose. Morphine and codeine were determined using gas chromatography-mass spectrometry (GC-MS), and M/C ratios ranged from 2.0 to 14.9, showing a secondary rise at later stages. These findings suggest that urinary Sb may serve as a useful supplementary biomarker for BM ingestion, thereby enhancing the accuracy of forensic toxicological interpretation and reducing false identification of heroin use.</p>","PeriodicalId":358,"journal":{"name":"Journal of Food and Drug Analysis","volume":"34 3","pages":"362-372"},"PeriodicalIF":3.3,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13592849/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149056738","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcome evaluation of percutaneous coronary intervention vs medical therapy alone in patients with chronic coronary syndrome. 慢性冠脉综合征患者经皮冠状动脉介入治疗与单纯药物治疗的疗效评价
IF 3.3 3区 农林科学 Q2 FOOD SCIENCE & TECHNOLOGY Pub Date : 2026-09-01 DOI: 10.38212/2224-6614.3604
Hsien-Yuan Chang, Hsin-Yu Fang, Mu-Shiang Huang, You-Zhen Chen, Di-Yung Chen, Edward Chia-Cheng Lai, Jung-Der Wang, Yi-Heng Li, Li-Jung Elizabeth Ku

This study provides real-world evidence by comparing the long-term clinical outcomes of percutaneous coronary intervention (PCI) versus medical therapy alone in patients with chronic coronary syndrome (CCS) diagnosed non-invasively, given the lack of evidence in this population. This retrospective cohort study (2013-2018) utilized data from a medical center's Cardiovascular Disease Databank, which was linked to national mortality records in Taiwan. Propensity score matching (PSM) and stabilized inverse probability of treatment weighting (IPTW) were applied to adjust for baseline differences between the PCI and medication-only groups. Major adverse cardiovascular events (MACE), including all-cause mortality, non-fatal myocardial infarction (MI), and revascularization, were compared between groups. After 1:4 propensity score matching, a total of 4369 patients were included (PCI, N = 1058; medication only, N = 3311). Adjusted Cox proportional hazards models showed that the PCI group had a higher hazard of MACE (aHR, 1.38 [95% CI, 1.22-1.56]), primarily driven by increased revascularization (aHR, 1.65 [95% CI, 1.39-1.95]), compared to the medication-only groups. No significant differences were observed in all-cause mortality (aHR, 1.13 [95% CI, 0.96-1.34]) or MI (aHR, 1.08 [95% CI, 0.77-1.52]). Furthermore, the mean total healthcare cost during the index year was US$3232 (SD = 9896) for the medication-only group, compared with US$10,931 (SD = 8781) for the PCI group. Among CCS patients diagnosed non-invasively, the medication-only group demonstrated comparable all-cause mortality and MI rates, but a significantly lower risk of revascularization compared with the PCI group, while incurring only onethird of the healthcare costs. Clinicians should carefully evaluate the benefits and risks of stent placement in CCS patients.

考虑到在该人群中缺乏证据,本研究通过比较经皮冠状动脉介入治疗(PCI)与单独药物治疗对非侵入性慢性冠状动脉综合征(CCS)患者的长期临床结果,提供了真实的证据。这项回顾性队列研究(2013-2018)利用了一家医疗中心心血管疾病数据库的数据,该数据库与台湾的全国死亡率记录有关。采用倾向评分匹配(PSM)和稳定治疗加权逆概率(IPTW)来调整PCI组和仅用药组之间的基线差异。主要不良心血管事件(MACE),包括全因死亡率、非致死性心肌梗死(MI)和血运重建术,在两组之间进行比较。经1:4倾向评分匹配后,共纳入4369例患者(PCI, N = 1058;单纯用药,N = 3311)。调整后的Cox比例风险模型显示,与单纯用药组相比,PCI组的MACE风险更高(aHR, 1.38 [95% CI, 1.22-1.56]),主要是由于血运重建增加(aHR, 1.65 [95% CI, 1.39-1.95])。两组全因死亡率(aHR, 1.13 [95% CI, 0.96-1.34])和心肌梗死(aHR, 1.08 [95% CI, 0.77-1.52])无显著差异。此外,在指标年内,仅用药组的平均总医疗费用为3232美元(SD = 9896),而PCI组为10931美元(SD = 8781)。在非侵入性诊断的CCS患者中,仅用药组显示出相当的全因死亡率和心肌梗死率,但与PCI组相比,血运重建的风险显着降低,而仅需三分之一的医疗费用。临床医生应仔细评估CCS患者支架置入术的益处和风险。
{"title":"Outcome evaluation of percutaneous coronary intervention vs medical therapy alone in patients with chronic coronary syndrome.","authors":"Hsien-Yuan Chang, Hsin-Yu Fang, Mu-Shiang Huang, You-Zhen Chen, Di-Yung Chen, Edward Chia-Cheng Lai, Jung-Der Wang, Yi-Heng Li, Li-Jung Elizabeth Ku","doi":"10.38212/2224-6614.3604","DOIUrl":"10.38212/2224-6614.3604","url":null,"abstract":"<p><p>This study provides real-world evidence by comparing the long-term clinical outcomes of percutaneous coronary intervention (PCI) versus medical therapy alone in patients with chronic coronary syndrome (CCS) diagnosed non-invasively, given the lack of evidence in this population. This retrospective cohort study (2013-2018) utilized data from a medical center's Cardiovascular Disease Databank, which was linked to national mortality records in Taiwan. Propensity score matching (PSM) and stabilized inverse probability of treatment weighting (IPTW) were applied to adjust for baseline differences between the PCI and medication-only groups. Major adverse cardiovascular events (MACE), including all-cause mortality, non-fatal myocardial infarction (MI), and revascularization, were compared between groups. After 1:4 propensity score matching, a total of 4369 patients were included (PCI, N = 1058; medication only, N = 3311). Adjusted Cox proportional hazards models showed that the PCI group had a higher hazard of MACE (aHR, 1.38 [95% CI, 1.22-1.56]), primarily driven by increased revascularization (aHR, 1.65 [95% CI, 1.39-1.95]), compared to the medication-only groups. No significant differences were observed in all-cause mortality (aHR, 1.13 [95% CI, 0.96-1.34]) or MI (aHR, 1.08 [95% CI, 0.77-1.52]). Furthermore, the mean total healthcare cost during the index year was US$3232 (SD = 9896) for the medication-only group, compared with US$10,931 (SD = 8781) for the PCI group. Among CCS patients diagnosed non-invasively, the medication-only group demonstrated comparable all-cause mortality and MI rates, but a significantly lower risk of revascularization compared with the PCI group, while incurring only onethird of the healthcare costs. Clinicians should carefully evaluate the benefits and risks of stent placement in CCS patients.</p>","PeriodicalId":358,"journal":{"name":"Journal of Food and Drug Analysis","volume":"34 3","pages":"407-416"},"PeriodicalIF":3.3,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13592853/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149056685","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identification of CA2 as a potential candidate gene involved in the therapeutic effect of Huatan Huoxue decoction on polycystic ovary syndrome: An integrated study of network pharmacology, Mendelian randomization, and experimental validation. 花坛活血汤治疗多囊卵巢综合征的潜在候选基因CA2的鉴定:网络药理学、孟德尔随机化和实验验证的综合研究
IF 3.3 3区 农林科学 Q2 FOOD SCIENCE & TECHNOLOGY Pub Date : 2026-09-01 DOI: 10.38212/2224-6614.3606
Chan Zhu, Yijin Zhang, Panwei Hu, Cong Qi, Qiu Chen, Hong Yang, Jing Li

Purpose: Huatan Huoxue decoction (HTHXD) is effective in treating polycystic ovary syndrome (PCOS); however, its underlying mechanisms of action remain unclear. Gene targets were obtained through Mendelian randomization (MR) analysis using druggable genes from public databases and genome-wide association study data for PCOS from the FinnGen R12 database. These targets were integrated with the active ingredients and protein targets of HTHXD retrieved from the TCMSP and BATMAN-TCM databases for network pharmacology analysis. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analyses were conducted. Core targets were validated using molecular docking. Experimental validation was performed using a letrozole-induced PCOS rat model treated with HTHXD, with key targets assessed via quantitative PCR (qPCR) and immunohistochemical staining. MR analysis identified 131 proteins causally related to PCOS, of which 52 with strong associations remained after quality control. Network pharmacology analysis revealed 549 gene targets and 243 active ingredients in HTHXD. The intersection of these datasets identified four core targets for HTHXD in PCOS treatment (CA2, CASP3, SNCA, and TSPO). Molecular docking identified tanshindiol B, 4-methylenemiltirone, and danshenol B in Danshen and crocetin in leech as key active components. HTHXD substantially ameliorated polycystic ovarian morphology and reduced corpora lutea in PCOS model rats. CA2 expression was significantly upregulated in PCOS ovarian tissue (P < 0.0001), and markedly reduced after HTHXD treatment, consistent with immunohistochemical findings. CA2 may serve as a potential candidate gene associated with the therapeutic response to HTHXD in PCOS, with tanshindiol B and crocetin as major active components.

目的:观察化痰活血汤治疗多囊卵巢综合征(PCOS)的临床疗效;然而,其潜在的作用机制尚不清楚。基因靶点通过孟德尔随机化(Mendelian randomization, MR)分析,利用公共数据库中的可用药基因和FinnGen R12数据库中的PCOS全基因组关联研究数据获得。这些靶点与从TCMSP和BATMAN-TCM数据库中检索的HTHXD的有效成分和蛋白质靶点进行整合,进行网络药理学分析。进行了基因本体和京都基因与基因组百科全书富集分析。利用分子对接对核心靶点进行验证。采用来曲唑诱导的PCOS大鼠模型,经HTHXD处理,通过定量PCR (qPCR)和免疫组织化学染色评估关键靶点。MR分析鉴定出131个与PCOS有因果关系的蛋白,其中52个在质量控制后仍具有很强的相关性。网络药理分析结果显示,黄芪丹参有549个基因靶点和243个有效成分。这些数据集的交集确定了HTHXD在PCOS治疗中的四个核心靶点(CA2, CASP3, SNCA和TSPO)。分子对接鉴定丹参中的丹杉地醇B、4-甲基咪替酮、丹酚醇B和水蛭中的西红花苷为关键活性成分。HTHXD显著改善PCOS模型大鼠多囊卵巢形态,减少黄体。CA2表达在PCOS卵巢组织中显著上调(P < 0.0001),经HTHXD治疗后显著降低,与免疫组织化学结果一致。CA2可能是与PCOS患者HTHXD治疗反应相关的潜在候选基因,其中坦地酚B和crocetin是主要活性成分。
{"title":"Identification of CA2 as a potential candidate gene involved in the therapeutic effect of Huatan Huoxue decoction on polycystic ovary syndrome: An integrated study of network pharmacology, Mendelian randomization, and experimental validation.","authors":"Chan Zhu, Yijin Zhang, Panwei Hu, Cong Qi, Qiu Chen, Hong Yang, Jing Li","doi":"10.38212/2224-6614.3606","DOIUrl":"10.38212/2224-6614.3606","url":null,"abstract":"<p><strong>Purpose: </strong>Huatan Huoxue decoction (HTHXD) is effective in treating polycystic ovary syndrome (PCOS); however, its underlying mechanisms of action remain unclear. Gene targets were obtained through Mendelian randomization (MR) analysis using druggable genes from public databases and genome-wide association study data for PCOS from the FinnGen R12 database. These targets were integrated with the active ingredients and protein targets of HTHXD retrieved from the TCMSP and BATMAN-TCM databases for network pharmacology analysis. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analyses were conducted. Core targets were validated using molecular docking. Experimental validation was performed using a letrozole-induced PCOS rat model treated with HTHXD, with key targets assessed via quantitative PCR (qPCR) and immunohistochemical staining. MR analysis identified 131 proteins causally related to PCOS, of which 52 with strong associations remained after quality control. Network pharmacology analysis revealed 549 gene targets and 243 active ingredients in HTHXD. The intersection of these datasets identified four core targets for HTHXD in PCOS treatment (CA2, CASP3, SNCA, and TSPO). Molecular docking identified tanshindiol B, 4-methylenemiltirone, and danshenol B in Danshen and crocetin in leech as key active components. HTHXD substantially ameliorated polycystic ovarian morphology and reduced corpora lutea in PCOS model rats. CA2 expression was significantly upregulated in PCOS ovarian tissue (P < 0.0001), and markedly reduced after HTHXD treatment, consistent with immunohistochemical findings. CA2 may serve as a potential candidate gene associated with the therapeutic response to HTHXD in PCOS, with tanshindiol B and crocetin as major active components.</p>","PeriodicalId":358,"journal":{"name":"Journal of Food and Drug Analysis","volume":"34 3","pages":"417-431"},"PeriodicalIF":3.3,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13592854/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149056687","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Simotang oral liquid alleviates functional dyspepsia-related motility dysfunction through Ca2+-dependent smooth muscle contraction and Nrf2/NF-κB modulation. 四磨汤口服液通过Ca2+依赖性平滑肌收缩和Nrf2/NF-κB调节缓解功能性消化不良相关的运动功能障碍。
IF 3.3 3区 农林科学 Q2 FOOD SCIENCE & TECHNOLOGY Pub Date : 2026-09-01 DOI: 10.38212/2224-6614.3605
Guo Mao, Chunxiang He, Jiaqin Liu, Dahua Wu, Puhua Zeng, Ye Mao

Functional dyspepsia (FD) is a disorder of gut-brain interaction involving heterogeneous motor, sensory, immune, and oxidative stress-related mechanisms. Simotang oral liquid (SMT), a traditional Chinese medicine formulation used for dyspeptic and gastrointestinal motility-related symptoms, has not been evaluated with an integrated clinical, functional, and molecular framework. This single-arm prospective pre-post study assessed gastric emptying by the 13C-octanoic acid breath test, gastric electrical activity by electrogastrography, postprandial tolerance by nutrient drink testing, symptom scores, serum biomarkers, and gastric antral tissue markers in patients with FD. FD-like mice were used for charcoal meal transit, smooth muscle strip tension, calcium channel blockade, and mucosal RNA sequencing. Public transcriptomic data from GSE169304 were analyzed to characterize FD-associated duodenal mucosal molecular features. SMT treatment was associated with reduced gastric emptying half-time, improved 3-cpm stability, lower gastric dysrhythmia, reduced Nepean Dyspepsia Index and Gastroparesis Cardinal Symptom Index scores, increased motilin and gastrin levels, lower malondialdehyde, higher superoxide dismutase activity, and lower tumor necrosis factor alpha and interleukin-6 levels. Paired gastric antral biopsy analyses showed increased α-smooth muscle actin and higher phosphorylation ratios of myosin light chain kinase and myosin light chain after SMT treatment. In mice, SMT increased intestinal transit, acetylcholine-induced smooth muscle tension, Cav1.2 abundance, calmodulin fluorescence, and p-MLCK/p-MLC signaling, while nifedipine reduced the SMT-associated phosphorylation changes. Transcriptomic analyses showed enrichment of smooth muscle contraction, calcium signaling, oxidative stress response, and Nrf2-related antioxidant pathways, while protein analyses showed reduced canonical NF-κB activation markers. The data are consistent with Ca2+-dependent smooth muscle contraction as the central motor pathway associated with SMT- related functional improvement in FD, with Nrf2/NF-κB modulation as a microenvironmental regulatory component.

功能性消化不良(FD)是一种肠脑相互作用障碍,涉及异质运动、感觉、免疫和氧化应激相关机制。四磨汤口服液(SMT)是一种用于治疗消化不良和胃肠动力相关症状的中药制剂,目前还没有综合临床、功能和分子框架进行评估。这项单臂前瞻性研究通过13c -辛酸呼吸试验评估FD患者的胃排空,通过胃电图评估胃电活动,通过营养饮料测试评估餐后耐受性,症状评分,血清生物标志物和胃窦组织标志物。用fd样小鼠进行炭粉转运、平滑肌条张力、钙通道阻断和粘膜RNA测序。对GSE169304的公开转录组学数据进行分析,以表征fd相关的十二指肠粘膜分子特征。SMT治疗与缩短胃排空时间、改善3-cpm稳定性、降低胃节律障碍、降低Nepean消化不良指数和胃轻瘫主要症状指数评分、增加胃动素和胃泌素水平、降低丙二醛、提高超氧化物歧化酶活性、降低肿瘤坏死因子α和白细胞介素-6水平相关。配对胃窦活检分析显示,SMT治疗后α-平滑肌肌动蛋白升高,肌球蛋白轻链激酶和肌球蛋白轻链磷酸化比例升高。在小鼠中,SMT增加了肠道转运、乙酰胆碱诱导的平滑肌张力、Cav1.2丰度、钙调素荧光和p-MLCK/p-MLC信号,而硝苯地平则降低了SMT相关的磷酸化变化。转录组学分析显示,平滑肌收缩、钙信号、氧化应激反应和nrf2相关抗氧化途径富集,而蛋白质分析显示,典型NF-κB激活标志物减少。这些数据与Ca2+依赖性平滑肌收缩作为与FD中SMT相关功能改善相关的中枢运动通路一致,Nrf2/NF-κ b调节是微环境调节成分。
{"title":"Simotang oral liquid alleviates functional dyspepsia-related motility dysfunction through Ca<sup>2+</sup>-dependent smooth muscle contraction and Nrf2/NF-κB modulation.","authors":"Guo Mao, Chunxiang He, Jiaqin Liu, Dahua Wu, Puhua Zeng, Ye Mao","doi":"10.38212/2224-6614.3605","DOIUrl":"10.38212/2224-6614.3605","url":null,"abstract":"<p><p>Functional dyspepsia (FD) is a disorder of gut-brain interaction involving heterogeneous motor, sensory, immune, and oxidative stress-related mechanisms. Simotang oral liquid (SMT), a traditional Chinese medicine formulation used for dyspeptic and gastrointestinal motility-related symptoms, has not been evaluated with an integrated clinical, functional, and molecular framework. This single-arm prospective pre-post study assessed gastric emptying by the 13C-octanoic acid breath test, gastric electrical activity by electrogastrography, postprandial tolerance by nutrient drink testing, symptom scores, serum biomarkers, and gastric antral tissue markers in patients with FD. FD-like mice were used for charcoal meal transit, smooth muscle strip tension, calcium channel blockade, and mucosal RNA sequencing. Public transcriptomic data from GSE169304 were analyzed to characterize FD-associated duodenal mucosal molecular features. SMT treatment was associated with reduced gastric emptying half-time, improved 3-cpm stability, lower gastric dysrhythmia, reduced Nepean Dyspepsia Index and Gastroparesis Cardinal Symptom Index scores, increased motilin and gastrin levels, lower malondialdehyde, higher superoxide dismutase activity, and lower tumor necrosis factor alpha and interleukin-6 levels. Paired gastric antral biopsy analyses showed increased α-smooth muscle actin and higher phosphorylation ratios of myosin light chain kinase and myosin light chain after SMT treatment. In mice, SMT increased intestinal transit, acetylcholine-induced smooth muscle tension, Cav1.2 abundance, calmodulin fluorescence, and p-MLCK/p-MLC signaling, while nifedipine reduced the SMT-associated phosphorylation changes. Transcriptomic analyses showed enrichment of smooth muscle contraction, calcium signaling, oxidative stress response, and Nrf2-related antioxidant pathways, while protein analyses showed reduced canonical NF-κB activation markers. The data are consistent with Ca<sup>2+</sup>-dependent smooth muscle contraction as the central motor pathway associated with SMT- related functional improvement in FD, with Nrf2/NF-κB modulation as a microenvironmental regulatory component.</p>","PeriodicalId":358,"journal":{"name":"Journal of Food and Drug Analysis","volume":"34 3","pages":"464-481"},"PeriodicalIF":3.3,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13592841/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149056695","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmacological potential of pomelo (Citrus maxima) peel: A bibliometric review of global research trends and future directions. 柚子皮的药理潜力:全球研究趋势和未来方向的文献计量学综述。
IF 3.3 3区 农林科学 Q2 FOOD SCIENCE & TECHNOLOGY Pub Date : 2026-09-01 DOI: 10.38212/2224-6614.3589
Indah Zunita Sari, Alma Nur Azizah, Fitriana Nur Hanifah, David Fernando, Agung Endro Nugroho, Abdul Rohman

Pomelo (Citrus maxima) is a widely cultivated tropical fruit with global production reaching approximately 8.55 million tons in 2023. This large-scale production generates a substantial amount of peel waste despite the fact that pomelo peel contains secondary metabolites with promising pharmacological potential. This study aimed to evaluate global research trends related to the pharmacological potential of pomelo peel using a bibliometric and review-based approach, as well as to identify future research directions. Data were collected from the Scopus database and filtered for English-language scientific articles, reviews, and conference proceedings. The analysis was performed using the Biblioshiny and VOSviewer software. In total, 251 relevant articles were identified between 2002 and 2025, with a significant increase in publications since 2020. Countries such as China, Vietnam, Nigeria, and Thailand have emerged as leading contributors, supported by institutions focused on natural product research. Research has evolved from compound characterization to pharmacological applications, including antioxidant, antidiabetic, antimicrobial, anticancer, anti-inflammatory, and other activities. Keyword analysis revealed a growing trend toward multidisciplinary approaches involving green synthesis, electroactive biosensors, and nanoencapsulation to enhance the stability and efficacy of bioactive compounds. Future studies should integrate nanotechnology and sustainable bioprocessing to advance the clinical validation and practical biomedical applications of pomelo peel.

柚子(Citrus maxima)是一种广泛种植的热带水果,2023年全球产量约为855万吨。尽管柚子皮含有具有良好药理潜力的次生代谢物,但这种大规模生产产生了大量的果皮废物。本研究旨在通过文献计量学和文献综述的方法来评估柚子皮药理潜力的全球研究趋势,并确定未来的研究方向。数据从Scopus数据库中收集,并筛选了英语科学文章、评论和会议记录。使用Biblioshiny和VOSviewer软件进行分析。在2002年至2025年期间,共确定了251篇相关文章,自2020年以来,出版物显著增加。中国、越南、尼日利亚和泰国等国家已成为主要贡献者,并得到了专注于天然产物研究的机构的支持。研究已经从化合物的表征发展到药理学应用,包括抗氧化、抗糖尿病、抗菌、抗癌、抗炎等活动。关键词分析表明,绿色合成、电活性生物传感器和纳米包封等多学科方法的发展趋势日益明显,以提高生物活性化合物的稳定性和有效性。未来的研究应结合纳米技术和可持续生物处理技术,推进柚皮的临床验证和实际生物医学应用。
{"title":"Pharmacological potential of pomelo (Citrus maxima) peel: A bibliometric review of global research trends and future directions.","authors":"Indah Zunita Sari, Alma Nur Azizah, Fitriana Nur Hanifah, David Fernando, Agung Endro Nugroho, Abdul Rohman","doi":"10.38212/2224-6614.3589","DOIUrl":"10.38212/2224-6614.3589","url":null,"abstract":"<p><p>Pomelo (Citrus maxima) is a widely cultivated tropical fruit with global production reaching approximately 8.55 million tons in 2023. This large-scale production generates a substantial amount of peel waste despite the fact that pomelo peel contains secondary metabolites with promising pharmacological potential. This study aimed to evaluate global research trends related to the pharmacological potential of pomelo peel using a bibliometric and review-based approach, as well as to identify future research directions. Data were collected from the Scopus database and filtered for English-language scientific articles, reviews, and conference proceedings. The analysis was performed using the Biblioshiny and VOSviewer software. In total, 251 relevant articles were identified between 2002 and 2025, with a significant increase in publications since 2020. Countries such as China, Vietnam, Nigeria, and Thailand have emerged as leading contributors, supported by institutions focused on natural product research. Research has evolved from compound characterization to pharmacological applications, including antioxidant, antidiabetic, antimicrobial, anticancer, anti-inflammatory, and other activities. Keyword analysis revealed a growing trend toward multidisciplinary approaches involving green synthesis, electroactive biosensors, and nanoencapsulation to enhance the stability and efficacy of bioactive compounds. Future studies should integrate nanotechnology and sustainable bioprocessing to advance the clinical validation and practical biomedical applications of pomelo peel.</p>","PeriodicalId":358,"journal":{"name":"Journal of Food and Drug Analysis","volume":"34 3","pages":"253-289"},"PeriodicalIF":3.3,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13592855/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149056724","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integration of freshness monitoring and active packaging technologies for aquatic products. 水产品新鲜度监测与活性包装技术的整合。
IF 3.3 3区 农林科学 Q2 FOOD SCIENCE & TECHNOLOGY Pub Date : 2026-09-01 DOI: 10.38212/2224-6614.3607
Maria Ali, Abdul Waheed Ghanghro, Bheem Raj Serani, Mahrukh Zakir

Aquatic products are nutritionally valuable but highly perishable, with quality loss driven by microbial spoilage, biochemical changes, including total volatile basic nitrogen (TVB-N), trimethylamine (TMA) and histamine, and physicochemical deterioration, including lipid oxidation, gas production and texture loss. Conventional packaging slows these processes but does not report real-time freshness. This review analyzes how active packaging (antimicrobial, antioxidant, enzyme-inhibiting, and oxygen-scavenging systems, including bio- and nanocomposites) can be combined with freshness monitoring technologies (colorimetric/pH indicators, gas sensors, biosensors, and digital tools such as radio frequency identification (RFID) and Internet of Things (IoT) systems) specifically for fish, shrimp, and mollusks. We first map key spoilage mechanisms and markers, then evaluate active systems for aquatic products and compare three main monitoring families in terms of sensitivity, response time, cost-complexity and qualitative technology readiness. Integrated case studies (peptide-grafted films, modified atmosphere packaging (MAP) with time-temperature integrators (TTIs), smart labels with active papers and battery-free near-field communication (NFC) systems) are critically assessed for scalability, cost-effectiveness, safety, and regulatory feasibility. The review concludes that low-cost visual indicators coupled to simple active functions are closest to near-term deployment, while sensor- and biosensor-based systems remain at prototype level. Future work must prioritize marker- and species-specific validation, safe and scalable material systems, techno-economic evaluation, and early integration of regulatory and consumer aspects to justify industrial adoption in aquatic supply chains.

水产品具有很高的营养价值,但极易变质,其质量损失主要由微生物变质、生化变化(包括总挥发性碱性氮(TVB-N)、三甲胺(TMA)和组胺)以及理化变质(包括脂质氧化、产气和质地损失)驱动。传统包装减缓了这些过程,但不能实时报告新鲜度。本文分析了活性包装(抗菌、抗氧化、酶抑制和除氧系统,包括生物和纳米复合材料)如何与新鲜度监测技术(比色/pH指标、气体传感器、生物传感器和数字工具,如射频识别(RFID)和物联网(IoT)系统)相结合,特别是对鱼、虾和软体动物。我们首先绘制了关键的腐败机制和标记物,然后评估了水产品的活性系统,并在灵敏度、响应时间、成本复杂性和定性技术就绪度方面比较了三种主要监测系列。综合案例研究(肽接片,带时间-温度集成器(tti)的改性大气包装(MAP),带活性纸张的智能标签和无电池近场通信(NFC)系统)的可扩展性,成本效益,安全性和监管可行性进行了严格评估。该综述得出的结论是,低成本的视觉指示器与简单的主动功能相结合,最接近近期部署,而基于传感器和生物传感器的系统仍处于原型水平。未来的工作必须优先考虑标记和物种特异性验证、安全和可扩展的材料系统、技术经济评估以及监管和消费者方面的早期整合,以证明在水产供应链中的工业采用是合理的。
{"title":"Integration of freshness monitoring and active packaging technologies for aquatic products.","authors":"Maria Ali, Abdul Waheed Ghanghro, Bheem Raj Serani, Mahrukh Zakir","doi":"10.38212/2224-6614.3607","DOIUrl":"10.38212/2224-6614.3607","url":null,"abstract":"<p><p>Aquatic products are nutritionally valuable but highly perishable, with quality loss driven by microbial spoilage, biochemical changes, including total volatile basic nitrogen (TVB-N), trimethylamine (TMA) and histamine, and physicochemical deterioration, including lipid oxidation, gas production and texture loss. Conventional packaging slows these processes but does not report real-time freshness. This review analyzes how active packaging (antimicrobial, antioxidant, enzyme-inhibiting, and oxygen-scavenging systems, including bio- and nanocomposites) can be combined with freshness monitoring technologies (colorimetric/pH indicators, gas sensors, biosensors, and digital tools such as radio frequency identification (RFID) and Internet of Things (IoT) systems) specifically for fish, shrimp, and mollusks. We first map key spoilage mechanisms and markers, then evaluate active systems for aquatic products and compare three main monitoring families in terms of sensitivity, response time, cost-complexity and qualitative technology readiness. Integrated case studies (peptide-grafted films, modified atmosphere packaging (MAP) with time-temperature integrators (TTIs), smart labels with active papers and battery-free near-field communication (NFC) systems) are critically assessed for scalability, cost-effectiveness, safety, and regulatory feasibility. The review concludes that low-cost visual indicators coupled to simple active functions are closest to near-term deployment, while sensor- and biosensor-based systems remain at prototype level. Future work must prioritize marker- and species-specific validation, safe and scalable material systems, techno-economic evaluation, and early integration of regulatory and consumer aspects to justify industrial adoption in aquatic supply chains.</p>","PeriodicalId":358,"journal":{"name":"Journal of Food and Drug Analysis","volume":"34 3","pages":"440-463"},"PeriodicalIF":3.3,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13592850/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149056733","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The protective potential of intestinal Bifidobacterium-derived extracellular vesicles with unique lipid composition against blue light-induced damage in retinal cells. 具有独特脂质组成的肠道双歧杆菌衍生的细胞外囊泡对蓝光诱导的视网膜细胞损伤的保护潜力。
IF 3.3 3区 农林科学 Q2 FOOD SCIENCE & TECHNOLOGY Pub Date : 2026-06-15 DOI: 10.38212/2224-6614.3554
Wei-Hsuan Hsu, Pin-Hsuan Su, Hao-Yuan Chien, Tzu-Ming Pan, Bao-Hong Lee

Bifidobacterium longum is a probiotic that resides in the intestine, and extracellular vesicles (EVs) released by microorganisms have garnered attention in recent years for their role in regulating host health. This study found that triacylglycerol, cholesteryl esters, and free fatty acid (18:0 and 16:0) are primarily composed of lipids in B. longum-derived EVs by lipidomics assay. Such lipid composition facilitates the entry of EVs into ARPE-19 cells and protects the cells from oxidative death induced by blue light exposure. Transcriptomic analysis revealed that treatment with B. longum-derived EVs can regulate phosphoinositide 3-kinase and mTOR, thereby enhancing the survival capacity of blue light-induced ARPE-19 cells. Intestinal microbiota is strongly associated with host disease, and this study provides a strategy suggesting that intestinal probiotic EVs might potentially be used in the future to protect eyes from damage caused by blue light sensitivity through the gut-eye axis.

长双歧杆菌是一种存在于肠道内的益生菌,近年来,微生物释放的细胞外囊泡(EVs)因其在调节宿主健康中的作用而受到关注。本研究通过脂质组学分析发现,三酰甘油、胆固醇酯和游离脂肪酸(18:0和16:0)主要由长叶螺旋藻衍生的EVs脂质组成。这种脂质组成有助于ev进入ARPE-19细胞,并保护细胞免受蓝光照射引起的氧化性死亡。转录组学分析显示,长叶芽胞杆菌衍生的ev可以调节磷酸肌肽3-激酶和mTOR,从而提高蓝光诱导的ARPE-19细胞的存活能力。肠道微生物群与宿主疾病密切相关,该研究提供了一种策略,表明肠道益生菌ev可能在未来被潜在地用于保护眼睛免受通过肠眼轴引起的蓝光敏感性损伤。
{"title":"The protective potential of intestinal Bifidobacterium-derived extracellular vesicles with unique lipid composition against blue light-induced damage in retinal cells.","authors":"Wei-Hsuan Hsu, Pin-Hsuan Su, Hao-Yuan Chien, Tzu-Ming Pan, Bao-Hong Lee","doi":"10.38212/2224-6614.3554","DOIUrl":"10.38212/2224-6614.3554","url":null,"abstract":"<p><p>Bifidobacterium longum is a probiotic that resides in the intestine, and extracellular vesicles (EVs) released by microorganisms have garnered attention in recent years for their role in regulating host health. This study found that triacylglycerol, cholesteryl esters, and free fatty acid (18:0 and 16:0) are primarily composed of lipids in B. longum-derived EVs by lipidomics assay. Such lipid composition facilitates the entry of EVs into ARPE-19 cells and protects the cells from oxidative death induced by blue light exposure. Transcriptomic analysis revealed that treatment with B. longum-derived EVs can regulate phosphoinositide 3-kinase and mTOR, thereby enhancing the survival capacity of blue light-induced ARPE-19 cells. Intestinal microbiota is strongly associated with host disease, and this study provides a strategy suggesting that intestinal probiotic EVs might potentially be used in the future to protect eyes from damage caused by blue light sensitivity through the gut-eye axis.</p>","PeriodicalId":358,"journal":{"name":"Journal of Food and Drug Analysis","volume":"34 2","pages":"104-116"},"PeriodicalIF":3.3,"publicationDate":"2026-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13391006/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148560493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluating the efficacy of I-fiber pearl on reducing body fat accumulation in obese females: A randomized, double-blind, and placebo-controlled trial. 评价i -纤维珍珠减少肥胖女性体脂积累的功效:一项随机、双盲、安慰剂对照试验。
IF 3.3 3区 农林科学 Q2 FOOD SCIENCE & TECHNOLOGY Pub Date : 2026-06-15 DOI: 10.38212/2224-6614.3593
Hung-Hsuan Kuo, Chia-Chun Chen, Ching-Chang Cho, Chun-Tse Tsai, Shiuan-Chih Chen, Chin-Lin Hsu

Obesity is a growing public health challenge worldwide, strongly linked to metabolic syndrome, type 2 diabetes, and cardiovascular disease. Inulin, a soluble, fermentable fiber derived mainly from Jerusalem artichoke and chicory, has been reported to improve weight management and metabolic health. This randomized, double-blind, placebo-controlled trial evaluated the effects of inulin-enriched tapioca pearls (I-fiber pearl) on body composition and lipid parameters in obese women. Methods: Fifty women (BMI ≥27 or waist >80 cm; age 20-50 years) were randomized to receive either I-fiber pearl or placebo (2 packs/day, 100 g/pack) for 12 weeks. Anthropometric indices, body composition, and blood biochemistry were assessed pre- and post-intervention. Results: After 12 weeks, the I-fiber group showed significant reductions in body weight, BMI, body fat mass, visceral fat, total cholesterol, and LDL cholesterol. I-fiber pearl improved body composition and lipid profiles, suggesting potential benefits as a functional supplement for obesity management.

肥胖是全球日益严重的公共卫生挑战,与代谢综合征、2型糖尿病和心血管疾病密切相关。菊粉是一种主要从菊芋和菊苣中提取的可溶性可发酵纤维,据报道可以改善体重管理和代谢健康。这项随机、双盲、安慰剂对照试验评估了富含菊粉的木薯珍珠(i纤维珍珠)对肥胖女性身体成分和脂质参数的影响。方法:50名女性(BMI≥27或腰围≥80 cm,年龄20-50岁)随机接受i纤维珍珠或安慰剂(2包/天,100克/包),为期12周。在干预前后分别评估人体测量指标、身体成分和血液生化。结果:12周后,i -纤维组的体重、BMI、体脂量、内脏脂肪、总胆固醇和低密度脂蛋白胆固醇显著降低。i -纤维珍珠改善了身体成分和脂质特征,表明作为肥胖管理的功能性补充剂具有潜在的益处。
{"title":"Evaluating the efficacy of I-fiber pearl on reducing body fat accumulation in obese females: A randomized, double-blind, and placebo-controlled trial.","authors":"Hung-Hsuan Kuo, Chia-Chun Chen, Ching-Chang Cho, Chun-Tse Tsai, Shiuan-Chih Chen, Chin-Lin Hsu","doi":"10.38212/2224-6614.3593","DOIUrl":"10.38212/2224-6614.3593","url":null,"abstract":"<p><p>Obesity is a growing public health challenge worldwide, strongly linked to metabolic syndrome, type 2 diabetes, and cardiovascular disease. Inulin, a soluble, fermentable fiber derived mainly from Jerusalem artichoke and chicory, has been reported to improve weight management and metabolic health. This randomized, double-blind, placebo-controlled trial evaluated the effects of inulin-enriched tapioca pearls (I-fiber pearl) on body composition and lipid parameters in obese women. Methods: Fifty women (BMI ≥27 or waist >80 cm; age 20-50 years) were randomized to receive either I-fiber pearl or placebo (2 packs/day, 100 g/pack) for 12 weeks. Anthropometric indices, body composition, and blood biochemistry were assessed pre- and post-intervention. Results: After 12 weeks, the I-fiber group showed significant reductions in body weight, BMI, body fat mass, visceral fat, total cholesterol, and LDL cholesterol. I-fiber pearl improved body composition and lipid profiles, suggesting potential benefits as a functional supplement for obesity management.</p>","PeriodicalId":358,"journal":{"name":"Journal of Food and Drug Analysis","volume":"34 2","pages":"159-171"},"PeriodicalIF":3.3,"publicationDate":"2026-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13391011/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148560508","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advanced hybrid-green ultrasound-infrared-microwave Trifolium repens essential oil isolation with multi-target ethnomedicine bioactivity against neuropathy, inflammation and multidrug-resistant infection. 先进的混合绿色超声-红外-微波三叶草精油分离,具有抗神经病变、炎症和多重耐药感染的多靶点民族药生物活性。
IF 3.3 3区 农林科学 Q2 FOOD SCIENCE & TECHNOLOGY Pub Date : 2026-06-15 DOI: 10.38212/2224-6614.3595
Sara Al Ayoubi, Ibrahim Abdelwahab, Maha Aboul-Ela, Abdalla El-Lakany, Karim Raafat

Trifolium repens (white clover) is rich in bioactive volatiles with therapeutic potential. This study developed an advanced hybrid ultrasound-infrared-microwave hydro-distillation (UIMHD) method for efficient essential oil (EO) isolation and investigated its active sesquiterpene, pseudoionone, for multi-mechanistic neuroprotection in diabetic neuropathy (DN). The optimized UIMHD system synergistically combined ultrasound cavitation, infrared heating, and microwave hydro-distillation, enhancing yield and reducing time versus conventional extraction. Gas chromatography-mass spectrometry (GC-MS) profiling identified pseudoionone as the dominant constituent. Pharmacological evaluations were performed in alloxan-induced diabetic mice to assess antidiabetic, anti-inflammatory, neuroprotective, and anticonvulsant activities. Cytokine modulation (TNF-α, IL-6, IL-10), oxidative stress markers (CAT, GSH, TBARS), and strychnine-induced seizure assays were conducted to elucidate mechanisms. The UIMHD technique increased T. repens essential oil (TR-EO) yield by 62.5% and shortened isolation time by 50%. Pseudoionone (49.16%) exhibited potent hypoglycemic and insulin-restorative effects, alleviated thermal hyperalgesia and tactile allodynia, and improved antioxidant defenses. Both the TR-EO and pseudoionone significantly down-regulated TNF-α and IL-6 while up-regulating IL-10, indicating anti-inflammatory cytokine balance restoration. Additionally, pseudoionone delayed strychnine-induced tonic seizures, suggesting functional involvement of glycinergic pathways. Strong antibacterial and antibiofilm activities were also observed against multidrug-resistant Shigella dysenteriae. The advanced UIMHD method provides a sustainable platform for isolating bioactive volatiles from T. repens. Pseudoionone emerges as a multi-target natural agent mitigating diabetic neuropathy via TNF-α/IL-6/IL-10 modulation, oxidative- stress restoration, and strychnine-sensitive GlyR potentiation.

白三叶草含有丰富的生物活性挥发物,具有治疗价值。本研究建立了一种先进的超声-红外-微波混合水蒸馏(UIMHD)高效分离精油(EO)的方法,并研究了其活性倍半萜伪离子酮对糖尿病神经病变(DN)的多机制神经保护作用。优化后的UIMHD系统将超声空化、红外加热和微波水蒸馏协同结合,与传统提取相比,提高了收率,缩短了时间。气相色谱-质谱(GC-MS)分析鉴定假离子为主要成分。在四氧嘧啶诱导的糖尿病小鼠中进行药理学评估,以评估其抗糖尿病、抗炎、神经保护和抗惊厥活性。通过细胞因子调节(TNF-α, IL-6, IL-10),氧化应激标志物(CAT, GSH, TBARS)和士的宁诱导癫痫发作实验来阐明其机制。UIMHD技术提高了T. repens精油(TR-EO)的收率62.5%,缩短了分离时间50%。假离子酮(49.16%)表现出有效的降血糖和胰岛素恢复作用,减轻热痛觉过敏和触觉异常性疼痛,提高抗氧化防御能力。TR-EO和假离子酮均显著下调TNF-α和IL-6,上调IL-10,表明抗炎细胞因子平衡得到恢复。此外,假离子酮延缓士的宁诱导的强直性癫痫发作,提示甘氨酸能通路的功能参与。对多重耐药痢疾志贺氏菌也有较强的抗菌活性和抗菌膜活性。先进的UIMHD方法提供了一个可持续的平台,分离生物活性挥发物。假离子酮作为一种多靶点的天然药物,通过调节TNF-α/IL-6/IL-10、氧化应激恢复和士的宁敏感的GlyR增强来缓解糖尿病神经病变。
{"title":"Advanced hybrid-green ultrasound-infrared-microwave Trifolium repens essential oil isolation with multi-target ethnomedicine bioactivity against neuropathy, inflammation and multidrug-resistant infection.","authors":"Sara Al Ayoubi, Ibrahim Abdelwahab, Maha Aboul-Ela, Abdalla El-Lakany, Karim Raafat","doi":"10.38212/2224-6614.3595","DOIUrl":"10.38212/2224-6614.3595","url":null,"abstract":"<p><p>Trifolium repens (white clover) is rich in bioactive volatiles with therapeutic potential. This study developed an advanced hybrid ultrasound-infrared-microwave hydro-distillation (UIMHD) method for efficient essential oil (EO) isolation and investigated its active sesquiterpene, pseudoionone, for multi-mechanistic neuroprotection in diabetic neuropathy (DN). The optimized UIMHD system synergistically combined ultrasound cavitation, infrared heating, and microwave hydro-distillation, enhancing yield and reducing time versus conventional extraction. Gas chromatography-mass spectrometry (GC-MS) profiling identified pseudoionone as the dominant constituent. Pharmacological evaluations were performed in alloxan-induced diabetic mice to assess antidiabetic, anti-inflammatory, neuroprotective, and anticonvulsant activities. Cytokine modulation (TNF-α, IL-6, IL-10), oxidative stress markers (CAT, GSH, TBARS), and strychnine-induced seizure assays were conducted to elucidate mechanisms. The UIMHD technique increased T. repens essential oil (TR-EO) yield by 62.5% and shortened isolation time by 50%. Pseudoionone (49.16%) exhibited potent hypoglycemic and insulin-restorative effects, alleviated thermal hyperalgesia and tactile allodynia, and improved antioxidant defenses. Both the TR-EO and pseudoionone significantly down-regulated TNF-α and IL-6 while up-regulating IL-10, indicating anti-inflammatory cytokine balance restoration. Additionally, pseudoionone delayed strychnine-induced tonic seizures, suggesting functional involvement of glycinergic pathways. Strong antibacterial and antibiofilm activities were also observed against multidrug-resistant Shigella dysenteriae. The advanced UIMHD method provides a sustainable platform for isolating bioactive volatiles from T. repens. Pseudoionone emerges as a multi-target natural agent mitigating diabetic neuropathy via TNF-α/IL-6/IL-10 modulation, oxidative- stress restoration, and strychnine-sensitive GlyR potentiation.</p>","PeriodicalId":358,"journal":{"name":"Journal of Food and Drug Analysis","volume":"34 2","pages":"176-193"},"PeriodicalIF":3.3,"publicationDate":"2026-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13390999/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148560523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Food and Drug Analysis
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
﹀
mjeditor
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1